Drug archive
Meglumine Antimoniate (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antiprotozoal, systemic
Description
Meglumine antimoniate (MEG-loo-meen an-ti-MOE-nee-ate) belongs to the group of medicines called antiprotozoals. Meglumine antimoniate is used to treat an infection called leishmaniasis (Bay sore or chiclero ulcer, espundia, kala-azar or black sickness, Oriental sore, ulcera de Bejuco, uta), which is caused by protozoa (tiny, one-celled organisms).
Meglumine antimoniate should be administered by or under the supervision of your doctor and is available in the following dosage form:
- Injection (France and Italy)
Brand Names
Some commonly used brand names are:
*† Not commercially available in the U.S. and Canada.